Valentis completes IL-2 Phase II enrollment

VLTS completed enrollment of 85 patients

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE